Division of Biliary Tract Surgery, Department of General Surgery, West China Hospital, Sichuan University.
Research Center for Biliary Diseases, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Int J Surg. 2024 Jul 1;110(7):4342-4355. doi: 10.1097/JS9.0000000000001403.
Current meta-analysis was performed to systematically evaluate the potential prognostic factors for overall survival among resected cases with gallbladder carcinoma.
PubMed, EMBASE, and the Cochrane Library were systematically retrieved and hazard ratio (HR) and its 95% confidence interval were directly extracted from the original study or roughly estimated via Tierney's method. Standard Parmar modifications were used to determine pooled HRs.
A total of 36 studies with 11 502 cases were identified. Pooled results of univariate analyses indicated that advanced age (HR=1.02, P =0.00020), concurrent gallstone disease (HR=1.22, P =0.00200), elevated preoperative CA199 level (HR=1.93, P <0.00001), advanced T stage (HR=3.09, P <0.00001), lymph node metastasis (HR=2.78, P <0.00001), peri-neural invasion (HR=2.20, P <0.00001), lymph-vascular invasion (HR=2.37, P <0.00001), vascular invasion (HR=2.28, P <0.00001), poorly differentiated tumor (HR=3.22, P <0.00001), hepatic side tumor (HR=1.85, P <0.00001), proximal tumor (neck/cystic duct) (HR=1.78, P <0.00001), combined bile duct resection (HR=1.45, P <0.00001), and positive surgical margin (HR=2.90, P <0.00001) were well-established prognostic factors. Pathological subtypes ( P =0.53000) and postoperative adjuvant chemotherapy ( P =0.70000) were not prognostic factors. Pooled results of multivariate analyses indicated that age, gallstone disease, preoperative CA199, T stage, lymph node metastasis, peri-neural invasion, lymph-vascular invasion, tumor differentiation status, tumor location (peritoneal side vs hepatic side), surgical margin, combined bile duct resection, and postoperative adjuvant chemotherapy were independent prognostic factors.
Various prognostic factors have been identified beyond the 8th AJCC staging system. By incorporating these factors into a prognostic model, a more individualized prognostication and treatment regime would be developed. Upcoming multinational studies are required for the further refine and validation.
本研究旨在通过系统评价手术切除胆囊癌患者的总生存预后相关的潜在因素。
系统检索 PubMed、EMBASE 和 Cochrane Library,直接从原始研究中提取风险比(HR)及其 95%置信区间,或通过 Tierney 法进行大致估计。采用标准的 Parmar 修正法来确定合并 HR。
共纳入 36 项研究,总计 11502 例患者。单因素分析的汇总结果表明,高龄(HR=1.02,P=0.00020)、合并胆囊结石(HR=1.22,P=0.00200)、术前 CA199 水平升高(HR=1.93,P<0.00001)、肿瘤 T 分期较晚(HR=3.09,P<0.00001)、淋巴结转移(HR=2.78,P<0.00001)、神经周围侵犯(HR=2.20,P<0.00001)、脉管侵犯(HR=2.37,P<0.00001)、血管侵犯(HR=2.28,P<0.00001)、分化差(HR=3.22,P<0.00001)、肝侧肿瘤(HR=1.85,P<0.00001)、近端肿瘤(颈部/胆囊管)(HR=1.78,P<0.00001)、联合胆管切除术(HR=1.45,P<0.00001)和切缘阳性(HR=2.90,P<0.00001)是公认的预后因素。病理亚型(P=0.53000)和术后辅助化疗(P=0.70000)不是预后因素。多因素分析的汇总结果表明,年龄、胆囊结石、术前 CA199、T 分期、淋巴结转移、神经周围侵犯、脉管侵犯、肿瘤分化状态、肿瘤位置(腹膜侧 vs 肝侧)、切缘、联合胆管切除术和术后辅助化疗是独立的预后因素。
除了第 8 版 AJCC 分期系统外,还确定了其他多种预后因素。通过将这些因素纳入预后模型,可以制定更个体化的预后和治疗方案。需要开展多中心研究来进一步完善和验证。